Abstract
Transplantation is a major clinical means to replace damaged or failed human organs to improve or save a patient’s life. The demand for organ transplantation has increased dramatically worldwide. However, the current dilemma is that the more that human organ transplants are performed, the less transplantable organs are available; the shortage of human organs is the major limiting factor for benefiting patients with organ dysfunction. Each year, thousands of patients are either removed from the waiting list due to death or become too sick for treatment. To solve the problem of organ shortages, several possible approaches have been considered and are under intensive investigations. These include artificial organs, tissue-engineered organs, and xenotransplantation (cross-species transplantation). While the former two hold hopes for the future, but with much higher social costs, xenotransplantation appears to have the potential to meet the current need of transplantation by providing adequate transplantable organs. However, several important issues, including immunological rejections, physiological incompatibilities, and safety, must be addressed before this approach can be a clinical reality. This review summarizes recent progress made in this field, the hurdles to be overcome, and the possible solutions for them.
References
Ashton-Chess J, Roussel JC, Manez R et al (2003) Cellular participation in delayed xenograft rejection of hCD55 transgenic pig hearts by baboons. Xenotransplantation 10:446–453
Bailey L, Nehlsen-Cannarella L, Concepcion W et al (1985) Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 254:3321–3329
Breimer ME (2011) Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era. Xenotransplantation 18:215–228
Burlak C, Paris LL, Chihara RK et al (2010) The fate of human platelets perfused through the pig liver: implications for xenotransplantation. Xenotransplantation 17:350–361
Calne RY, White HJ, Herbertson BM et al (1968) Pig to baboon liver xenografts. Lancet 7553:1176–1778
Crikis S, Cowan PJ, d’Apice AJ (2006) Intravascular thrombosis in discordant xenotransplantation. Transplantation 82:1119–1123
Ekser B, Long C, Echeverri GJ et al (2010) Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance. Am J Transplant 10:273–285
Ekser B, Gridelli B, Veroux M et al (2011) Clinical pig liver xenotransplantation: how far do we have to go? Xenotransplantation 18:158–167
Farr AD (1980) The first human blood transfusion. Med Hist 24:143
Galili U, Shohet SB, Kobrin E et al (1988) Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 263:17755–17762
Groth CG, Korsgren O, Tibell A et al (1994) Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344:1402–1404
Hering BJ, Wijkstrom M, Graham ML et al (2006) Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 12:301–303
Hisashi Y, Yamada K, Kuwaki K et al (2008) Rejection of cardiac xenografts transplanted from α1,3-galactosyltransferase gene-knockout (GalTKO) pigs to baboons. Am J Transplant 8:2516–2526
Ide K, Wang H, Liu J et al (2007) Role for CD47-SIRPα signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A 104:5062–5066
Lai L, Kolber-Simonds D, Park KW et al (2002) Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295:1089–1092
Makowka L, Cramer DV, Hoffman A et al (1995) The use of pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 59:1654–1659
Ott HC, Matthiesen TS, Goh SK et al (2008) Perfusion –decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 14:213–221
Patience C, Takeuchi Y, Weiss A (1997) Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3:282–286
Petersen TH, Calle EA, Zhao L et al (2010) Tissue-engineered lungs for in vivo implantation. Science 329:538–541
Phelps CJ, Koike C, Vaught TD et al (2003) Production of α1,3-galactosyltransferase-deficient pigs. Science 299:411–414
Reemtsma K, McCracken BH, Schlegel JU et al (1964) Heterotransplantation of the kidney: two clinical experiences. Science 143:700
Rodriguez Umana H (1995) Grafting of bone from a dog into the human skull: an historical note. Plast Reconstr Surg 96:1481
Schultheiss D, Denil J, Jonas U (1997) Rejuvenation in the early 20th century. Andrologia 29:351
Song KH, Kang YJ, Jin UH et al (2010) Cloning and functional characterization of pig CMP-N-acetylneuraminic acid hydroxylase for the synthesis of N-glycolylneuraminic acid as the xenoantigenic determinant in pig-human xenotransplantation. Biochem J 427:179–188
Starzl E, Fung J, Tzakis A et al (1993) Baboon-to-human liver transplantation. Lancet 341:65–71
Tisato V, Cozzi E (2012) Xenotransplantation: an overview of the field. Methods Mol Biol 885:1–16
Uygun BE, Soto-Gutierrez A, Yagi H et al (2010) Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16:814–820
Wang D, Coscoy L, Zylberberg M et al (2002) Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 99:15687–15692
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Wei, Z. (2017). Xenotransplantation. In: Doria, C. (eds) Contemporary Liver Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-07209-8_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-07209-8_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07208-1
Online ISBN: 978-3-319-07209-8
eBook Packages: MedicineReference Module Medicine